Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00233142
Status:
COMPLETED
Last Update Posted:
2016-04-15
First Post:
2005-09-13
Brief Title:
Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients
Sponsor:
Syracuse University
Organization:
Syracuse University
Study Overview
Official Title:
Expressive Writing Complementary Treatment for Diabetes
Status:
COMPLETED
Status Verified Date:
2009-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will determine whether the psychological benefits of expressive writing extend to diabetic patients how long the benefits will last and whether additional expressive writing booster sessions will lead to greater and more sustained improvement in diabetes symptoms and well-being
Detailed Description:
Diabetes is one of the leading causes of blindness kidney failure and nontraumatic lower extremity amputation in the United States Conditions such as stress and depression have been shown to worsen diabetic symptoms Data indicate that expressive writing an activity during which individuals deal with stressful experiences by writing about them on paper has beneficial effects on psychological and physiological outcomes This study will determine whether diabetes patients can benefit from expressive writing This study will also determine the duration of the benefits and the effectiveness of booster sessions in improving their diabetic symptoms
Participants will be randomly assigned to engage in expressive writing or neutral writing for 18 months Participants in the expressive writing group will write about traumatic or stressful events participants in the neutral writing group will write about neutral topics that do not affect them emotionally Some participants in the expressive writing group will receive an additional 4 months of booster sessions of expressive writing All participants will undergo interviews blood collection physical exams and complete clinical scales on their disease status quality of life and psychological well-being these assessments will occur at study entry every 4 months during the study and at the end of the study
Participants will be randomly assigned to engage in expressive writing or neutral writing for 18 months Participants in the expressive writing group will write about traumatic or stressful events participants in the neutral writing group will write about neutral topics that do not affect them emotionally Some participants in the expressive writing group will receive an additional 4 months of booster sessions of expressive writing All participants will undergo interviews blood collection physical exams and complete clinical scales on their disease status quality of life and psychological well-being these assessments will occur at study entry every 4 months during the study and at the end of the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01AT002477 | NIH | None | httpsreporternihgovquickSearchR01AT002477 |